← FDA DRUG APPROVALS

FDA ANDA · ANDA218661

SELENIOUS ACID

Sponsor: CIPLA

APPLICATION
ANDA218661
TYPE
ANDA
ORIGINAL APPROVAL
2025-07-21
LATEST ACTION
2025-07-21
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

SELENIOUS ACIDDiscontinued
SELENIOUS ACID EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML) · SOLUTION · INTRAVENOUS
SELENIOUS ACIDDiscontinued
SELENIOUS ACID EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) · SOLUTION · INTRAVENOUS

Approval history

2025-07-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →